JPMorgan’s preliminary terms for a note linked to IBIT promise $1,000 per $1,000 invested if the ETF’s final price is at least 70% of its starting level. Below that threshold, investors bear IBIT’s full decline. If IBIT is at or above its starting price on November 30, 2027, the note is automatically called, paying at least $1,300. Otherwise, it runs to November 2028, when gains above the starting price are multiplied by 1.5.
The preliminary pricing supplement was filed with the SEC on November 20 by JPMorgan Chase Financial Company LLC, with JPMorgan Chase & Co. as guarantor. Pricing is expected around November 24, and issuance around November 30, subject to possible delays. Final terms will set IBIT’s starting price, the call premium (currently at least $300 per $1,000), and the note’s estimated value (currently about $960 and no lower than $940 per $1,000).
The barrier is based only on IBIT’s closing price on November 24, 2028, compared with its close on the pricing date; earlier dips below the threshold do not affect the maturity payout. At a final price from 70% to 100% of the start, investors receive their $1,000 principal but no coupon or profit. Below 70%, they incur IBIT’s entire loss: for example, a 40% decline returns $600, while a final price at 69.99% of the starting level returns $699.90; exactly 70% returns $1,000. This is not a 30% loss buffer—the threshold creates a sharp payout drop. If IBIT starts at $40, the barrier would be $28. The fund’s reported net asset value was about $40 on November 12, and its roughly $33–$58 52-week range represents a decline of about 42% from high to low.
If the note is called, the minimum $300 premium is a fixed total payment for roughly one year, not an annual rate, and does not increase if IBIT rises further. At maturity, a price above the starting level returns principal plus 1.5 times IBIT’s gain, without a cap. The article says the note can outperform through the fixed early premium, the protection against a final decline of up to 30%, or the 1.5-times upside factor. It can lag if IBIT rises more than 30% by the 2027 review, because the automatic call ends the investment. The illustrative comparisons assume the minimum premium, full payment by the issuer, and IBIT prices measured on the same dates; they exclude the fund’s 0.25% sponsor fee and any note-selling commission and are not forecasts.
Investors own JPMorgan Financial’s payment promise, not IBIT shares or bitcoin. The parent guarantee covers what the payout formula owes, not the investment outcome; the article notes that the SEC treats issuer credit risk as separate from exposure to the linked asset. If IBIT is delisted, liquidated, or terminated without a successor fund, JPMorgan Financial may accelerate the notes and have the calculation agent determine the payment. The notes will not be exchange-listed, so early sellers depend on dealer bids that may reflect JPMorgan’s credit and time to maturity as well as IBIT’s price; a price above the barrier does not ensure a $1,000 bid.
JPMorgan’s model estimated the note at about $960 when the preliminary supplement was prepared, versus a $1,000 purchase price; the filing says the final estimate will be at least $940. The article attributes the difference to selling, structuring, and hedging costs built into structured-note issue prices. Selling commissions are capped at $7.50 per $1,000 for brokerage accounts; certain fee-based advisory accounts pay no commission and have a price of at least $992.50. The filing does not specify how JPMorgan hedges this note, and the bank’s reported IBIT holdings mentioned in a separate disclosure concern a different position. The model estimate is not an offer to repurchase the note.




